Results 231 to 240 of about 276,156 (305)

Unusual molecular architecture of a human gut microbiota β-mannanase reveals a new CBM family

Łoś N, Lelėnaitė I, Willats WGT, Terrapon N, Morales-García AL, Yau HCL, Lowe EC, Bolam DN.   +7 more
europepmc   +1 more source

Uncovering differences in rye and wheat degradation by human gut microbiota applying a quantitative multi-metaOmics <i>in vitro</i> approach. [PDF]

Curr Res Microb Sci
Arnold CB, Kelder A, Woltemate S, Geffers R, von Felde A, Knudsen KEB, Visscher C, Vital M.   +7 more
europepmc   +1 more source

RORγt‐APCs: The New Masters of Oral Tolerance

Barrier Immunity, EarlyView.
ABSTRACT Oral tolerance is defined by the hypo‐responsiveness of our body to fed antigens, and its failure can lead to immune‐mediated diseases, such as allergy, chronic inflammation and autoimmune diseases. Decades of research have demonstrated that antigen‐presenting cells (APCs) promote oral tolerance by inducing regulatory T cells (Tregs) and/or ...
Thierry Gauthier, WanJun Chen
wiley   +1 more source

Temporal response patterns of human gut microbiota to dietary fiber. [PDF]

Imeta
Lin X, Wang C, Liu B, Zhu Y, Zhai R, Zhang C.   +5 more
europepmc   +1 more source

Novel Organelle‐Based Intracellular Immunity With Mechanistic and Therapeutic Implications

Barrier Immunity, EarlyView.
A conceptual framework illustrating how PAMPs/DAMPs initiate barrier, innate, adaptive, and intracellular immune responses, with organelle‐based intracellular immunity serving as a central integrator linking metabolism, inflammatory signaling, and therapeutic interventions to restore immune homeostasis.
Keman Xu, Shih‐Yu Hung, Fatma Saaoud, Ying Shao, Yifan Lu, Juanjuan Liu, Bo Yuan, Haiyan Xiang, Hong Wang, Xiaofeng Yang   +9 more
wiley   +1 more source

Genomic and functional characterization of a Butyricicoccus porcorum strain isolated from human gut microbiota. [PDF]

mSystems
Zhao N, Geng P, Perez AG, Maya AC, Yadav B, Du Y, Ge Y.   +6 more
europepmc   +1 more source

Gut microbiota‐related modulation of immune mechanisms in post‐infarction remodelling and heart failure

ESC Heart Failure, Volume 12, Issue 2, Page 942-954, April 2025.
Abstract The immune system has long been recognized as a key driver in the progression of heart failure (HF). However, clinical trials targeting immune effectors have consistently failed to improve patient outcome across different HF aetiologies. The activation of the immune system in HF is complex, involving a broad network of pro‐inflammatory and ...
Johann Roessler, Friederike Zimmermann, Bettina Heidecker, Ulf Landmesser, Arash Haghikia   +4 more
wiley   +1 more source

Host interactions of <i>Lactococcus lactis</i> and <i>Streptococcus thermophilus</i> support their adaptation to the human gut microbiota. [PDF]

Appl Environ Microbiol
Lugli GA, Argentini C, Tarracchini C, Longhi G, Mancabelli L, Bianchi MG, Taurino G, Amaretti A, Candeliere F, Bussolati O, Milani C, Turroni F, Ventura M.   +12 more
europepmc   +1 more source

Antibacterial Activity of Heteropolytungstates Against Proteus mirabilis

European Journal of Inorganic Chemistry, EarlyView.
We investigated the in vitro antibacterial activity of several heteropolytungstates against P. mirabilis, a drug‐resistant pathogen. All tested polyanions inhibited bacterial growth, with the Preyssler–Pope–Jeannin polyanion P5W30 exhibiting the highest activity (MIC = 0.78 mg/mL).
Nour El Ghouch, Ahmad Asaad, Rana El Hajj, Sahar Khandan, Matthias S. Ullrich, Ulrich Kortz   +5 more
wiley   +1 more source

Analysis of Human Gut Microbiota Enzymes for Biotechnological and Food Industrial Applications. [PDF]

Foods
Torres-Sánchez A, Luque G, Ortiz P, Ruiz-Rodríguez A, López-Moreno A, Aguilera M.   +5 more
europepmc   +1 more source